MONTREAL, QUEBEC--(Marketwire - April 30, 2008) - Ambrilia Biopharma Inc. (TSX: AMB) today announced that Dr. Philippe Calais, President and Chief Executive Officer, will present the Company and its projects at BioFinance 2008 to be held in Toronto, May 6-8. This presentation will take place on Wednesday, May 7, at 3:00 pm local time, in the Trinity I room.
